Michael Khalil

Sep 8, 2024 | nature.com | Shahzad Ahmad |Aniket Mishra |Marisol Herrera-Rivero |Joshua C. Bis |Myriam Fornage |Gennady V Roshchupkin | +13 more

AbstractNeurofilament light chain (NfL) levels in circulation have been established as a sensitive biomarker of neuro-axonal damage across a range of neurodegenerative disorders. Elucidation of the genetic architecture of blood NfL levels could provide new insights into molecular mechanisms underlying neurodegenerative disorders.

Apr 12, 2024 | nature.com | Michael Khalil |Sylvain Lehmann |Markus Otto |Fredrik Piehl |Stefan Bittner |Maria Pia Sormani | +8 more

AbstractNeurofilament proteins have been validated as specific body fluid biomarkers of neuro-axonal injury. The advent of highly sensitive analytical platforms that enable reliable quantification of neurofilaments in blood samples and simplify longitudinal follow-up has paved the way for the development of neurofilaments as a biomarker in clinical practice.

Sep 1, 2023 | ajp.com.au | Michael Khalil |Kelly Lin |Nicholas O’Donoghue

There is a 60 day dispensing reality disconnect in residential aged care, says Gerard Stevens Politics might be the contest of ideas, but sometimes trenchant positions lead to tunnel vision and vital issues can be missed or misunderstood. Amid the heated debate over the impact of the 60-day dispensing (60DD) policy on community pharmacy, IThis content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.